![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
1. Cisapride
2. Propulsid
3. R 51619
4. R-51619
5. R51619
1. Cisapride Monohydrate
2. 260779-88-2
3. Propulsid
4. Acenalin
5. Vzv0a4i38w
6. Cisapride Hydrate
7. Risamol
8. Propulsin
9. Alimix
10. Benzamide, 4-amino-5-chloro-n-((3r,4s)-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, Hydrate (1:1), Rel-
11. Benzamide, 4-amino-5-chloro-n-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, Cis Monohydrate
12. 4-amino-5-chloro-n-[(3s,4r)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide;hydrate
13. Benzamide, 4-amino-5-chloro-n-[(3r,4s)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-, Hydrate (1:1), Rel-
14. Smr000449272
15. Unii-vzv0a4i38w
16. R-51619
17. Cisapride (monohydrate)
18. Cpd000449272
19. Cisapride [mart.]
20. Cisapride Hydrate (1:1)
21. Mls000758247
22. Mls001423985
23. Schembl467064
24. Chembl1546244
25. Dtxsid60948954
26. Cisapride Monohydrate [mi]
27. Hms2051g13
28. (r,s)-cisapride Monohydrate
29. Hy-14149a
30. Cisapride Monohydrate [who-dd]
31. Ccg-100794
32. Nc00044
33. Q27292115
Molecular Weight | 484.0 g/mol |
---|---|
Molecular Formula | C23H31ClFN3O5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 483.1936270 g/mol |
Monoisotopic Mass | 483.1936270 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 581 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)